Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 January 2023 | Story Lacea Loader | Photo Evert Kleynhans
Dr Dolf van Niekerk
Dr Dolf van Niekerk.

The University of the Free State (UFS) would like to express its condolences to the family and friends of South African author, Dr Dolf van Niekerk, on his passing.

Dr Van Niekerk, the recipient of an honorary doctorate from the UFS, passed away on 31 December 2022. The UFS awarded a Doctor of Letters to Dr Dolf van Niekerk during its April 2021 graduation ceremony. 
 
Dr Van Niekerk was a celebrated author who also achieved fame as a dramatist and radio presenter. An alumnus of the UFS, he received a BA degree from the university cum laude in 1949. He also played a role in academia and was an emeritus professor at the University of Pretoria until his retirement in 1994. His work includes 27 books in philosophy, poetry, fiction, drama, and memoirs, for which he has received numerous awards. These include the Eugene Marais Prize, the MER Prize, and the Scheepers Award for Youth Literature.
 
“Dr van Niekerk is a Kovsie alumnus with a deep connection to the Free State. He played a significant role in the country’s literary history, and it was an honour for the university to award him with an honorary degree. A wordsmith of note, Dr van Niekerk’s contributions to South African literature, radio, and stage will live on," says Prof Francis Petersen, Rector and Vice-Chancellor.

News Archive

Newly operational sequencing unit in genomics at UFS
2016-09-09

Description: Next Generation Sequencing  Tags: Next Generation Sequencing

Dr Martin Nyaga and his research assistant,
Tshidiso Mogotsi in the Next Generation
Sequencing Laboratory.
Photo: Charl Devenish

The Next Generation Sequencing (NGS) unit at the UFS was established as an interdisciplinary facility under the Directorate for Research Development, Faculty of Health Sciences and Faculty of Natural and Agricultural Sciences.

The aim of the NGS facility is to aid internal and external investigators undertaking studies on Deoxyribonucleic acid (DNA) sequencing, assembly and bioinformatics approaches using the more advanced Illumina MiSeq NGS platform.

The NGS unit became operational in 2016 and is managed by Dr Martin Nyaga and administered through the office of the Dean, Faculty of Health Sciences, under the leadership of Prof Gert Van Zyl. Dr Nyaga has vast experience in microbial genomics, having done his PhD in Molecular Virology.

He has worked and collaborated with globally recognised centres of excellence in Prokaryotic and Eukaryotic genomics, namely the J. Craig Venter Institute and the Laboratory of Viral Metagenomics, Rega Institute, among others.

The unit has undertaken several projects and successfully generated data on bacterial, viral and human genomes. Currently, work is ongoing on bacterial and fungal metagenomics studies through 16S rRNA sequencing.

In addition, the unit is also working on plasmid/insert sequencing and whole genome sequencing of animal and human rotaviruses. The unit has capacity to undertake other kinds of panels like the HLA, Pan-cancer and Tumor 15 sequencing, among others.

Several investigators from the UFS including but not limited to Prof Felicity Burt, Prof Wijnand Swart, Dr Frans O’Neil, Dr Trudi O'Neill, Dr Charlotte Boucher, Dr Marieka Gryzenhout and Dr Kamaldeen Baba are actively in collaboration with the NGS unit.

The unit has also invested in other specialised equipment such as the M220 Focused-ultrasonicator (Covaris), 2100 Bioanalyzer system (Agilent) and the real-time PCR cycler, the Rotor-Gene Q (Qiagen), which both the UFS and external investigators can use for their research.

Investigators working on molecular and related studies are encouraged to engage with Dr Nyaga on how they would like to approach their genomics projects at the UFS NGS unit. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept